There is an increasing awareness of bronchiectasis in children and adolescents, a chronic pulmonary disorder associated with poor quality-of-life for the child/adolescent and their parents, recurrent exacerbations and costs to the family and health systems. Optimal treatment improves clinical outcomes. Several national guidelines exist, but there are no international guidelines.
To update clinicians on the management of children and adolescents with bronchiectasis based on the ERS guideline that provides evidence-based recommendations for managing children and adolescents (aged ≤18-years) with bronchiectasis unrelated to cystic fibrosis (CF).
Lecture and case-based discussion
European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis
Following this webinar, participants will be able to
- Recognise the burden of bronchiectasis on children and their families
- Describe the objectives of managing children/adolescents with bronchiectasis
- Know the recommendations relating to diagnosing and undertaking the minimum investigations when evaluating a child/adolescent with chronic suppurative lung disease
- Understand reasons for the various recommendations
- Be aware of the guideline’s recommendations on antibiotic treatment of exacerbations, pathogen eradication, long-term antibiotic therapy, asthma-type therapies (inhaled corticosteroids, bronchodilators), mucoactive drugs, airway clearance, disease monitoring, factors to consider before surgical treatment and the reversibility and prevention of bronchiectasis in children/adolescents
Those involved in the care of children/adolescents with bronchiectasis, including specialists in respiratory medicine, infectious diseases, paediatricians, thoracic surgeons, primary care physicians, pharmacists, respiratory physiotherapists, nurses, regulatory authorities, pharmaceutical companies and policy makers. Also, adolescents and parents of children/adolescents with bronchiectasis
ERS will file an accreditation request to the European Board for Accreditation in Pneumology (EBAP), 1 CME credit per 1-hour attendance. The CME credit will be granted upon attendance during the LIVE webinar only (attendance of at least 60 minutes is required).
What is a webinar?
The webinar closely simulates a lecture-based teaching experience. The speaker can interact with the audience, just as in a classroom setting.
This webinar comprises of a 40-minute lecture followed by a 20-minute question-and-answer sessions. During the webinar you will be asked to share your opinion on issues related to the topic using interactive polls.
All participants will be able to hear the lecturer and see the slides throughout the presentation. As a participant you will be able to pose questions or discuss ideas with the other participants via the text chat facility and the speaker will respond to the questions via the microphone.
More information will be communicated in due course.
- Please log in to the webinar 20 minutes before it is scheduled to commence. If you have any technical difficulties whilst trying to log in or during the session please contact email@example.com
- Check Central European Summer Time.
- To achieve the best quality, we recommend to stop all other programmes and to avoid downloading anything from the internet during your connection to the lecture.
- Please also ensure that your audio settings are not set to mute and adjust the volume to a comfortable level.
Diseases / methods
- Airway diseases
- Paediatric respiratory diseases
- Respiratory infections
- Cell and molecular biology
- General respiratory patient care
- Adult Pulmonologist/Clinician
- General Practitioner
- Medical Student
- Physician in Pulmonary Training
- Respiratory physiotherapist
- Respiratory therapist
- Sales, Marketing
- Thoracic Surgeon